Christopher Lewis Stone Insider Trading $PDLI PDL BIOPHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Lewis Stone.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Lewis Stone. Christopher Lewis Stone is VP, Gen. Counsel & Secretary in PDL BIOPHARMA, INC. ($PDLI).
Christopher Lewis Stone in PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Christopher Lewis Stone: VP, Gen. Counsel & Secretary
Holdings: 405,559 shares
Current Value: $896,285
Latest Transaction: Dec 17 2020
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Christopher Lewis Stone in PDL BIOPHARMA, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | S | 2.56 | 200,000 | 512,000 | 405,559 | 605.6 K to 405.6 K (-33.03 %) |
| Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | S | 2.56 | 200,000 | 512,000 | 405,559 | 605.6 K to 405.6 K (-33.03 %) |
| Dec 04 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | D | 0.00 | 11,544 | 0 | 605,559 | 617.1 K to 605.6 K (-1.87 %) |
| Dec 04 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | D | 0.00 | 11,544 | 0 | 605,559 | 617.1 K to 605.6 K (-1.87 %) |
| Apr 07 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Payment of Exercise | F | 3.33 | 2,686 | 8,944 | 617,103 | 619.8 K to 617.1 K (-0.43 %) |
| Apr 07 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Payment of Exercise | F | 3.43 | 1,240 | 4,253 | 619,789 | 621 K to 619.8 K (-0.20 %) |
| Jan 10 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Grant | A | 0.00 | 422,078 | 0 | 621,029 | 199 K to 621 K (+212.15 %) |
| Jan 10 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Grant | A | 0.00 | 422,078 | 0 | 621,029 | 199 K to 621 K (+212.15 %) |
| Apr 01 2019 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Option Exercise | A | 3.72 | 817,610 | 3,041,509 | 817,610 | |
| Dec 28 2018 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | D | 0.00 | 228,255 | 0 | 198,951 | 427.2 K to 199 K (-53.43 %) |
| Dec 28 2018 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Payment of Exercise | F | 3.02 | 3,581 | 10,815 | 427,206 | 430.8 K to 427.2 K (-0.83 %) |
| Sep 27 2018 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Option Exercise | A | 2.52 | 339,623 | 855,850 | 339,623 | |
| Jun 12 2018 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Option Exercise | A | 2.94 | 700,500 | 2,059,470 | 700,500 | |
| Dec 19 2017 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | D | 0.00 | 17,959 | 0 | 430,787 | 448.7 K to 430.8 K (-4.00 %) |
| Mar 07 2017 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Grant | A | 2.04 | 214,372 | 437,319 | 448,746 | 234.4 K to 448.7 K (+91.47 %) |
| Dec 15 2016 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | D | 0.00 | 1,935 | 0 | 234,374 | 236.3 K to 234.4 K (-0.82 %) |
| Jan 28 2016 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Grant | A | 3.22 | 101,860 | 327,989 | 236,309 | 134.4 K to 236.3 K (+75.76 %) |
| Oct 05 2015 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Grant | A | 4.95 | 15,291 | 75,690 | 155,764 | 140.5 K to 155.8 K (+10.89 %) |
Page: 1